Supreme Versus Proseal Laryngeal Mask Airways in Infants
Comparison of the Supreme™ And Proseal™ Laryngeal Mask Airways in Infants: A Prospective Randomised Clinical Study
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
In this study, the Supreme and ProSeal LMAs in infants were compared by measuring their performance characteristics, including insertion features, ventilation parameters, induced changes in hemodynamics and rates of postoperative complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable surgery
Started Apr 2016
Shorter than P25 for not_applicable surgery
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2017
CompletedFirst Submitted
Initial submission to the registry
August 7, 2017
CompletedFirst Posted
Study publicly available on registry
August 16, 2017
CompletedAugust 16, 2017
August 1, 2017
8 months
August 7, 2017
August 11, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
performance characteristics
insertion time in minutes
operation duration
Secondary Outcomes (1)
haemodynamics
operation duration
Study Arms (2)
ProSeal group
ACTIVE COMPARATORThis group received the ProSeal LMA for supraglottic airway intubation and ventilation during anaesthesia.
Supreme group
ACTIVE COMPARATORThis group received the Supreme LMA for supraglottic airway intubation and ventilation during anaesthesia.
Interventions
Eligibility Criteria
You may qualify if:
- scheduled for elective, minor (\<1 hour duration), lower abdominal surgery, including unilateral herniorrhaphy and unilateral orchidopexy
You may not qualify if:
- premature birth, potentially difficult airway, clinically significant upper respiratory tract infection and risk of aspiration, such as gastro-oesophageal reflux disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Luce V, Harkouk H, Brasher C, Michelet D, Hilly J, Maesani M, Diallo T, Mangalsuren N, Nivoche Y, Dahmani S. Supraglottic airway devices vs tracheal intubation in children: a quantitative meta-analysis of respiratory complications. Paediatr Anaesth. 2014 Oct;24(10):1088-98. doi: 10.1111/pan.12495. Epub 2014 Jul 30.
PMID: 25074619BACKGROUNDOba S, Turk HS, Isil CT, Erdogan H, Sayin P, Dokucu AI. Comparison of the Supreme and ProSeal laryngeal mask airways in infants: a prospective randomised clinical study. BMC Anesthesiol. 2017 Sep 5;17(1):125. doi: 10.1186/s12871-017-0418-z.
PMID: 28870163DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Sibel Oba, MD
Sisli Hamidiye Etfal Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist, M.D.
Study Record Dates
First Submitted
August 7, 2017
First Posted
August 16, 2017
Study Start
April 27, 2016
Primary Completion
December 31, 2016
Study Completion
January 31, 2017
Last Updated
August 16, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share
We can only share data as Exel or SSPS, but not with patient names.